Regulation and control of new drugs in the United States are the responsibilities of the federal FDA (http://www.fda.gov). The FDA regulates the following:

• Initiation of new Clinical Trials and clinical trials with new drug candidates by requiring the filing and approval of an IND.

• Marketing of a new drug product or an existing drug product for a new application by requiring the filing and approval of an NDA or a BLA.